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Abstract
Background: According to the International Classification of Headache Disorders 3, post-traumatic headache (PTH)
attributed to traumatic brain injury (TBI) is a secondary headache reported to have developed within 7 days from
head injury, regaining consciousness following the head injury, or discontinuation of medication(s) impairing the
ability to sense or report headache following the head injury. It is one of the most common secondary headache
disorders, and it is defined as persistent when it lasts more than 3 months.
Main body: Currently, due to the high prevalence of this disorder, several preclinical studies have been conducted
using different animal models of mild TBI to reproduce conditions that engender PTH. Despite representing a
simplification of a complex disorder and displaying different limitations concerning the human condition, animal
models are still a mainstay to study in vivo the mechanisms of PTH and have provided valuable insight into the
pathophysiology and possible treatment strategies. Different models reproduce different types of trauma and have
been ideated in order to ensure maximal proximity to the human condition and optimal experimental
reproducibility.
Conclusion: At present, despite its high prevalence, PTH is not entirely understood, and the differential
contribution of pathophysiological mechanisms, also observed in other conditions like migraine, has to be clarified.
Although facing limitations, animal models are needed to improve understanding of PTH. The knowledge of
currently available models is necessary to all researchers who want to investigate PTH and contribute to unravel its
mechanisms.
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Background - definition, epidemiology, why
animal models are needed?
Animal models have been used for centuries in biomed-
ical research to increase scientific knowledge and, des-
pite increasing ethical concerns, nowadays remain one
of the main tools to improve the understanding of dis-
eases [1–3] Their use is based on the anatomical, physio-
logical, and pathological similarities between humans
and different species, especially mammals [4, 5].
Investigations in the field of pain in humans, consider-
ing both the subjective nature of the phenomenon and
the numerous ethical issues, have often been limited
and, consequently, the use of animal models has been
larger than in other scientific areas throughout history
[6]. Nowadays, pain animal models are a matter of de-
bate, and their replacement in favor of more extensive
tests in humans or the use of alternative models has
been promoted [4, 7, 8] but remains a utopia [4]. The
absence of biochemical or genetic biomarkers that help
to predict pain occurrence and evolution, and response
to treatments, favor animal models remaining a mainstay
in pain science to test hypotheses and finally to improve
the health of humans and animals [6]. This fact is no
doubt applicable also to post-traumatic headache (PTH).
According to the International Classification of Head-
ache Disorders 3 [ICHD-3], PTH attributed to traumatic
head injury is a secondary headache that develops within
7 days after head or neck trauma (or after regaining con-
sciousness following the trauma) [9]. Importantly, in all
patients a traumatic injury to head or neck precedes the
onset of PTH. However some patients may have pre-
existing primary headaches; therefore, the ICHD-3 cri-
teria require a significant worsening in close temporal
relation to the trauma. PTH is acute when lasting less
than 3 months, and persistent when lasting more than 3
months. PTH can be attributed to a mild, moderate or
severe traumatic brain injury (TBI), whiplash, or craniot-
omy. However, we will focus on PTH attributed to TBI.
The most common causes of mTBI leading to PTH in-
clude traffic accidents and falls; to a much lesser extent,
also violence and sport injuries are reported [10]. PTH
may be the only symptom following TBI, but cognitive,
mood, sleep, and autonomic symptoms can also be
present [11, 12]. In a large cohort study about the occur-
rence of post-concussion symptoms after complicated
and uncomplicated mild traumatic brain injury (mTBI)
it was seen that headache could be present at three and
six months post-injury, as well as dizziness, noise sensi-
tivity, fatigue/tiring more easily, feeling depressed/tear-
ful, feeling frustrated or impatient, forgetfulness/poor
memory, poor concentration, taking longer to think and
restlessness [13].
Epidemiological studies of PTH have shown conflict-
ing results, which might be due to methodological
differences such as classification of PTH, the time point
of evaluation, or selection criteria [14]. Nevertheless, due
to the high incidence of head trauma, PTH is an import-
ant secondary headache disorder [15, 16]. A recent mul-
ticentric study noted that mild or worse PTH after
uncomplicated mTBI (no intracranial abnormalities in
CT scans) was present in 30% of patients at 3 months
and in 27% at 6 months [13]. In complicated mTBI (i.e.
mTBI with intracranial abnormalities in CT scans), the
incidence of PTH was only slightly higher: 33% of pa-
tients at 3 months and 30% of patients at 6 months [13].
According to the Akershus Study on 30,000 persons
aged 30–44 years the 1-year prevalence of chronic post-
traumatic headache was 0.21% [17], another study noted
that the lifetime prevalence was 4,7% in men and 2,4%
in women [15].
There is currently not enough evidence to support any
clear cut risk factors worth presenting as established
[18]. However, some findings may be considered as ini-
tial evidence. It has been reported that younger age, fe-
male sex. and a pre-injury history of headache are
significantly related to a higher risk of developing PTH
[19–21]. Females were more likely to report any head-
aches over a 12 month-period after injury than males,
and individuals with a history of headache were more
likely to report headaches compared to those without
[19]. Moreover, a Danish study found that women were
more likely to develop chronic PTH than men, but not
other post-traumatic symptoms [20]. However, it is
worth noting that in some longitudinal studies, no asso-
ciation has been found between sex and headache after
traumatic injury [10, 22]. In a study in war veterans of
Iraq and Afghanistan, the prevalence of PTH was slightly
higher among men than women [23].
Most studies have reported that the most frequent
clinical presentation is migraine-like headache [24–26],
others have reported a higher incidence of tension-type-
like headache [27, 28] or more than one type of head-
ache in a patient [10]. To a much lesser extent, other
types of headaches such as cluster-like headache,
cervicogenic-like headache, or unclassifiable headache
are reported [10, 24, 25, 27].
Currently, animal models of mTBI and concussion are
being used for studying PTH. These models, which con-
sist of experimental penetrating or nonpenetrating head
injury, are utilized for studies that, for obvious ethical
reasons, cannot be performed in humans. In particular,
graded cortical contusions or subcortical injuries are
produced by precisely controlled brain deformations in
order to study the influence of contact velocity and level
of deformation on the anatomic and functional severity
of TBI. According to current knowledge, the changes in
the physiology of the brain, brainstem, and spinal cord
following pathologic phenomena result to be a function
Benemei et al. The Journal of Headache and Pain           (2020) 21:90 Page 2 of 10
of both contact velocity and the amount of tissue de-
formation [29]. Despite being a simplification of com-
plex disorders, animal models are therefore necessary
and can provide us with valuable insights into patho-
physiology and possible treatment of PTH [24].
Main text
Animal models of PTH
In the last years, different animal models of mTBI have
been used to reproduce the traumatic events preceding
PTH and thus allowing the study of this condition and
its associated symptoms (Fig. 1). However, it is necessary
to specify that, up to date, there are no well-established
models of PTH, as all the models are related to TBI.
Models of mTBI can be divided into penetrative and
non-penetrative injuries. Among penetrative injuries,
two models have been developed: the Controlled Cor-
tical Impact injury (CCI) and the Lateral Fluid Percus-
sion injury (LFP). CCI is realized using a pneumatic
impactor that hits the cortex through a unilateral crani-
otomy [29], whereas LFP induces brain injury by gener-
ating a pulse of pressurized fluid to the intact dura
mater through a craniotomy [30] (Table 1). Among non-
penetrative injuries, in the weight-drop injury model a
projectile-shaped weight with a smooth surface falls
from a predetermined height and hits the head (fixed or
not) of an anesthetized animal [31], while in the blast in-
jury model, the animal is usually exposed to an explosive
detonation [32] (Table 1, Fig. 1). It is worth noting that
penetrative injury models are the most used in the head-
ache field, although the non-penetrative weight drop
model is the most relevant from a translational point of
view [1].
From a clinical standpoint, following mTBI, patients
may present PTH with clinical features frequently re-
sembling migraine or tension-type headache [33]. Im-
portantly, not all people after mTBI suffer from PTH,
and the lack of disease development may also occur in
animals used to model it. Considering that animals can
not verbally refer pain, in vivo models have focused on
pain-related behavioral phenotypes as indicative of head-
ache. The onset of pain-related behaviors not previously
present just after mTBI suggests that PTH may be stud-
ied in animal models as well. The frequent PTH pheno-
type similar to migraine and the existence of animal
pain-related behaviors aimed to study this primary head-
ache, probably explain why certain behavioral tests have
been exploited in the study of PTH [34]. It could be ar-
gued that observed features are just modeling TBI with-
out any PTH, and this can not be excluded at all.
However, some initial evidence just points to the other
direction. For instance, cranial hypersensitivity has been
assessed as a marker of cephalic cutaneous allodynia, a
common migraine feature [35] that is reported in PTH
patients as well [36], reflecting sensitization of the tri-
geminal system [37]. The behavioral test used to evalu-
ate the mechanical pain hypersensitivity in rodents
consists in the application of calibrated or electronic von
Frey monofilaments to their head, usually in the perior-
bital region, assessing head retraction as a response [38].
This test is widely used and has been applied to different
animal models, such as CCI [39] and mild-closed head
injury (mCHI ) [40], a type of weight-drop injury.
Von Frey filaments can be used to assess also hind
paw hypersensitivity, which represents a marker of
extra-cephalic allodynia, reflecting central sensitization
at a higher level than the trigeminal nucleus caudalis.
Nevertheless, this symptom is less commonly described
in headache patients, including migraine [37], and in
PTH, it has been reported immediately following mTBI
in nonfixed head weight-drop injury [41] but not in fixed
head weight-drop models [34], making its interpretation
difficult in translational terms. If on one side, hind paw
hypersensitivity cannot be considered specific for PTH,
on the other, it can still be an additional tool to evaluate
if PTH involves central sensitization. In this context,
provocation studies assessing pericranial and hind paw
hypersensitivity after administration of glyceryl trinitrate
(GTN) or bright light stress (BLS) have been used to
study susceptibility to headache triggers and therefore to
investigate the presence of persistent central
sensitization, a hallmark of headache chronification, in
both migraine [42] and PTH models [34, 41].
However, not all PTH patients present allodynia, and
other features have been investigated, using other
evoked or spontaneous behavioral models. The multidi-
mensional nature of PTH pain can be studied observing
the spontaneous locomotor and exploratory activities in
an open field environment, associating headache-
behaviors to a reduction in such activities [34]. Other
cognitive symptoms are tested by observing the presence
of deficits in recognition memory using a Novel Object
Recognition test [34], which could reflect the impair-
ment due to the severity of the brain injury. Moreover,
the aversive state of pain has been evaluated using the
Conditioned Place Preference model and the Condition
Place Aversion model. The Conditioned Place Preference
model evaluates whether mCHI rodents, compared to
sham controls, prefer spending more time in a chamber
where a specific treatment is administered [34]. The
Condition Place Aversion model assesses if drug-treated
rodents no longer avoid chambers where a trigger was
previously administered [34]. These behavioral models
may not be sensitive enough to distinguish migraine
from PTH from a phenotypical standpoint, even though
they provide fundamental insight in the evaluation of
the efficacy of specific treatments to alleviate headache-
like symptoms in PTH. In this context, response to
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certain treatments could allow the elaboration of hypotheses
on specific pathophysiological mechanisms that can be acti-
vated in PTH. Moreover, since certain PTH features such as
cognitive impairment may also result from the brain injury
itself, positive response to migraine treatments with the
consequent application of ex iuvantibus criterion may further
support their association with migraine rather than the
exclusively underlying mTBI sequelae.
Concerning pathophysiological mechanisms, it is
worth noting that the current models of PTH have
Fig. 1 Most common animal models of traumatic brain injury (TBI). Penetrative injuries (a,b). The lateral fluid percussion, LFP injury (a) is
generated by a pulse of pressurized fluid to the intact dura mater through a craniotomy. The controlled cortical impact, CCI injury (b) is done by
means of a pneumatic impactor that hits the cortex through a craniotomy. In penetrative injuries the dura may be damaged, especially in
controlled cortical impact models. Non-penetrative injuries (c,d). In the weight-drop injury model (c) a weight falls from a predetermined height
(h), hitting the head. In the blast injury model (d), the animal is exposed to an explosive detonation. Non-penetrative models are the most used
to study post-traumatic headache. In TBI models, animals are previously anesthetized
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disclosed specific pathways that can be present in pri-
mary headaches, such as migraine. Bree et al. showed
persistent hypersensitivity to headache triggers in con-
cussed animals [34], a finding that may explain persist-
ent PTH and which is present as well in chronic
migraine. In their study, 14 days after mTBI, when the
mCHI-evoked cephalic hypersensitivity had disappeared,
a systemic administration of low doses of GTN resulted
in renewed cephalic tactile hypersensitivity, which could
be attenuated by administration of sumatriptan or pre-
vented by chronic treatment with murine anti-calcitonin
gene-related peptide (CGRP) antibodies, started immedi-
ately after mTBI. Moreover, they showed a sumatriptan-
induced conditioned place preference in mCHI animals,
but not in sham controls. Considering also that triptans,
migraine-specific acute medications, have presynaptic re-
ceptors that inhibit CGRP release, overall, these findings
suggest that pain-related behaviors in the current mTBI
model depend on peripheral CGRP.
In another study [41], cutaneous allodynia (both at peri-
orbital and hind paw level) after mTBI was also attenuated
by the administration of murine anti-CGRP antibodies, a
fact that once again underlines a CGRP-dependent
mechanism in acute PTH. Furthermore, they observed that
early treatment after mTBI with anti-CGRP antibodies pre-
vented the re-establishment of cutaneous allodynia after
provocation with BLS, but a single administration right be-
fore BLS was not able to avoid its onset. These findings
support the hypothesis that once central sensitization is
established, this headache-related feature becomes inde-
pendent from CGRP and may involve other mechanisms.
It seems that all the studies mentioned above strongly
corroborate the hypothesis that common pathways, espe-
cially those involving CGRP, are present in both migraine
and PTH, raising the question whether the two conditions
could represent a continuum within a spectrum of head-
ache disorders, especially considering that animal models
of PTH have achieved reproducing migraine-like features,
as seen in humans. On the one side, although being care-
ful as data come from not specific PTH models, the exist-
ence of a link between PTH and migraine may be
hypothesized; on the other, the same lack of specificity
makes it difficult to identify the pathophysiological differ-
ences between the two disorders.
However, it is more likely that from distinct initial
pathophysiology, some shared mechanisms are activated






- It affords control all over biomechanical parameters.
- It lacks the risk of rebound or second-hit injury, as can happen
with gravity-driven devices.
- The dura mater is not pierced during the procedure
- Allows researchers to quantify the relationship between
measurable engineered parameters (e.g., force, velocity, depth
of tissue deformation) and the extent of (either functional
and/or tissue) impairment.
- Injury can be controlled to produce a range of injury
magnitudes, allowing gradable functional impairment, tissue
damage, or both.
- It is the best characterized model of PTH in rodents
- The need for a craniotomy contrast with the fact that the
majority of PTH cases results from non-penetrative head
injuries.
- Craniotomy per se can produce inflammation and
sensitization of meningeal afferents, thus proper selection of
controls is mandatory.




- It produces a robust and reproducible behavioral phenotype
(cephalic hypersensitivity) that is suited to the study of PTH in
rodents.
- It exhibits predictive validity and the reliability of the
technique enables the evaluation of various pharmacological
and genetic manipulations before or after the induction of
injury.
- It does lack translational relevance primarily due the invasive
craniotomy required, and subsequent compromise of dural
integrity even before the injury is applied.
- Still limited application.
- As only hind paw allodynia was evaluated, it is difficult to




- It produces a robust behavioral phenotype, with strong
translational relevance making it eminently suitable for the
study of PTH.
- The severity of the injury can be modified by adjusting the
weight and height from which it is dropped.
- Variations exist as to whether the skull or scalp are kept intact
during the procedure
- Increased translational value as the location and magnitude of
the head traumas that lead to PTH are highly variable.
- The variability of the procedure itself; may hardly ensure that
hits are identical to each other and also to avoid rebound
second hits
- Pharmacological intervention is not applicable.
Blast injury - The experimental setup allows for the exposure of animals to
a “pure” blast event without reflected shock fronts from the
ground or other surfaces.
- Issues surrounding standardization and implementation are a
concern and hindrance for the widespread uptake of blast
injury-related models
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and converge in a similar subset of characteristics while
other features may require the involvement of com-
pletely different pathways. For example, Navratilova
et al. [41] showed that CGRP plays a major role in acute
PTH and in promoting the transition to a persistent
form of PTH, while it is probably less determining the
symptoms once central sensitization is established,
therefore once PTH has already become persistent. This
fact seems to be partially different from chronic mi-
graine patients, in whom, first, central sensitization is
also present but together with elevated CGRP levels
[43], and second, treatment with anti-CGRP antibodies
is effective in chronic migraine [42, 44, 45]. Although
chronic migraine animal models evaluating specific re-
sponse to murine anti-CGRP drugs are lacking and hu-
man, and animal models are not directly comparable,
the coexistence of other different mechanisms in chronic
migraine and persistent PTH could still be supposed and
should be further investigated.
Considering that no well-established animal models of
PTH exist at present, the animal models mentioned above
of mTBI displaying headache behaviors have helped the de-
scription of some of the pathophysiological pathways con-
sidered to be involved in PTH. Further studies need to be
conducted to better investigate in PTH the role of certain
mechanisms elicited in the study of mTBI and to assess
their differential expression in migraine. For example, neu-
rometabolic changes, where neuronal damage may be pro-
duced by glutamate release and an increase of extracellular
potassium, have been shown in models of LFP concussive
brain injury [46]. Other relevant mechanisms include neu-
roinflammation, as a consequence of glial cell activation
after mTBI, as demonstrated in mCHI models that espe-
cially highlighted the role of mast cells [47]. At the same
time, neuroinflammation seems to promote central nervous
system excitability and therefore facilitates cortical spread-
ing depression [48, 49], another pathway that has been ob-
served in animal models of mTBI [39, 50] and implicated in
the activation of the trigeminal sensory system.
Hereupon, it is fundamental to dispose of both PTH
and migraine models and, although intrinsically differ-
ent, applying similar measures and comparing them may
represent a good strategy to detect similarities and dif-
ferences in underlying mechanisms, therefore enabling
further understanding of these disorders. For example,
mechanisms related to cortical spreading depression
could be studied, or features such as photophobia and
its mechanisms can be investigated. Besides, considering
as well that one of the most critical risk factors for de-
veloping PTH after mTBI is migraine [19], the study of
both PTH and migraine, for example by reproducing
mTBI in genetic migraine models, may provide further
information, allowing comparison to exclusively mi-
graine or PTH models.
At present, the preclinical study of PTH has to face
other significant limitations. For example, current PTH
animal models have shown impaired cognitive activities
as well as altered responses to BLS, suggestive of
migraine-like features as observed in human PTH stud-
ies [51]. PTH without migraine features is therefore not
well studied, probably due to the lack of representative
animal models that reproduce conditions similar to
TTH, reflecting the fact that the underlying mechanisms
of this disorder are still poorly understood. However, a
recent study [51] on human PTH has shown different
testing profiles in migraine-like PTH compared to TTH-
like PTH, observing more cephalic and extracephalic
thermal hypoalgesia that was accompanied by cephalic
mechanical hyperalgesia in TTH-like patients. These
findings should be further investigated in animal models
of PTH with the objective of better characterizing these
two subgroups and defining whether certain features,
commonly tested, such as mechanical cephalic hyper-
algesia are specific of one type or not.
Other questions, such as the multiple concussions and
sub-concussive hits and their relation to PTH and its
chronification have not been sufficiently addressed. An-
other issue is that the predisposition towards PTH in
humans is not only associated with previous migraines
but also with a history of psychiatric illnesses and co-
morbid psychiatric disorders [52], making it difficult to
reproduce these aspects in animal models. All limita-
tions considered, in the absence of better and well-
established PTH models, at present mTBI animal models
should still be considered useful in studying PTH when
pain-related behavioral phenotypes indicative of head-
ache are present.
Pathophysiology
Do we need other models of head injury to study PTH?
Up to date, research in the field of PTH has not yet led
to the full understanding of the disease and its successful
treatment; it may be useful to understand whether
changes in preclinical models help to improve their reli-
ability and to promote the transfer from bench to bed-
side. The general pros and cons of TBI animal models
are summarized in Table 2. As a premise, it is essential
to consider that, although models of concussion, or
mTBI as well as non-penetrating models are more rele-
vant to PTH, some of the findings discussed below come
from experimental models of more severe TBI and pene-
trating models. The inclusion of these latter models has
been considered useful to give a comprehensive overview
of all possible mechanisms that, in some way, may can-
didate to drive traumatic injuries to PTH.
Over the last years, animal models have substantially
improved and can now reproduce the different types of
TBI, especially due to the more precise mechanical
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control on blast force and direction. Each model repro-
duces only one or two types of TBI similarly to human
ones [53]. Given the heterogeneity of brain injury patho-
genesis in humans, the characterization of biochemical
and structural changes within each model and their com-
parative analysis may help to identify leading mechanisms
of TBI and PTH better. Moye et al., in their review [54],
summarized the most investigated mechanisms of PTH
reproduced by different model systems of mTBI. The au-
thors divided existing studies into two groups according
to the types of observed molecules. The first group in-
cludes alterations in protein expression, specifically: i) 1.
increased levels of CGRP in the trigeminal nucleus cauda-
lis [55] and brainstem [39] in CCI model; ii) Toll-like re-
ceptor 4 (TLR4) impact on neuroinflammation pathways
in weight-drop model with craniotomy and pituitary ad-
enylate cyclase-activating polypeptide neuroprotective
effect [56]; iii) brain-derived neurotrophic factor upregula-
tion in spinal cord in LFP model [50]. Inflammatory medi-
ators mostly represent the second group: i) increased level
of TNF-α mRNA expression in injured cortex in CCI
model [57]; ii) different activity of matrix metalloprotein-
ases (MMP-2 and MMP-9) in close and open head injury
models [58]; iii) potential role of dural mast cells degranu-
lation in neuroinflammation and PTH in closed-head
weight drop model and blast injury model [47].
Various observations showed relevant biological differ-
ences between animal models and humans. For example,
it has been shown that between human and experimen-
tal animal astrocytes [59], there are morphological and
functional differences, which in turn may lead to differ-
ences in secondary and tertiary changes after injury in
humans and animals. Therefore, provisional modifica-
tions of the models should be aimed at reproducing the
entire cascade of biochemical reactions associated with
TBI in humans. It is safe to assume that early-stage in-
vitro models may help to limit errors resulted from dif-
ferences between humans and animals. For example, a
model based on the blast impact (the compressed air-
driven shock tube) on either the rodent neuroblastoma/
glioblastoma hybrid cells or human neuroblastoma cells
in tissue culture plates shows good prerequisites for
studying primary, secondary and tertiary neurobiological
changes TBI [60].
In order to perform appropriate modeling, it is neces-
sary to underline the difference between PTH and TBI.
Unlike TBI, which is defined by biochemical and bio-
physical tissue responses to trauma, PTH is a sensation,
a subjective experience per definition. It follows that
PTH modeling is impossible without assessing TBI, but
it is also aimed at linking biochemical processes with be-
havioral responses. Several tests used for assessing pain
perception, cognitive impairment, and depression in ani-
mals have been described [61]. However, as far as the
clinical effects of TBI in humans are concerned, all these
conditions may be superimposed in one person, whereas
it is difficult to differentiate them by the behavioral tests
in animal models. This complexity could be resolved, at
least partly, via the collection of more data within the
frameworks of the different models.
Sex differences in pain hypersensitivity
Migraine is a gendered disease, but gender/sex influence
on PTH remains a grey area even if initial suggestions
come from epidemiology [19–23]. Experimental studies
suggest that increased estrogen levels may enlarge the
receptive field of peripheral nociceptors in the trigeminal
system [62]. Estrogens also affect the activity of the
bradykinin B2 receptor and decrease the concentration
of various neurotransmitters involved in its nociceptive
pathways, such as substance P, glutamate, gamma-
aminobutyric acid, dopamine, serotonin, and adrenaline
[63, 64]. Estrogens and progesterone levels also affect
the endogenous opioid system, mostly through μ-type of
opioid receptors [65]. An experimental study in a rat
model of PTH shows that females have an extended
state of cephalic hyperalgesia, increased responsiveness
to a headache trigger, and have a poorer response to
anti-CGRP-therapy than males [66]. Notwithstanding
these initial experimental premises and epidemiological
findings that in humans suggest gender-driven differ-
ences, up to date, there are not enough data to draw a
precise scenario about sex-related differences in PTH, in
order to parallel it to migraine.
Is TBI necessary and sufficient or not?
Pre-existing migraine or tension-type headache (TTH)
has been claimed as a predictor for the development of
Table 2 Pros and cons of animal models
Advantages Disadvantages
- Precise control of physical parameters during trauma - Differences in gross anatomy as compared to humans
(e.g. lack of gyri/sulci)
- Trauma can be ‘dissected’ to focus on particular physical mechanisms, for example,
rotational acceleration
- Differences in the physiology and timewise progression
of pathology as compared to humans
- Possibility to control age and genetics (including sex) - Few models for concussion available
- Possibility to monitor post-traumatically development of pathologies with exact time-
tables for evaluation and possibility to include baseline data
- Difficult to translate outcome parameters for concussion
between rodents and humans
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PTH [24], although no evidence exists [26]. A hypothesis
to understanding the pathophysiology of persistent PTH
is that TBI could ‘trigger’ or accentuate a TTH or a mi-
graine pre-existing to the trauma [67]. Since in humans
the most frequent traumatic injury associated with PTH
is a mild closed head trauma, a concussion model
evoked by a mild closed head injury has been developed
[1]. The weight-drop concussion was associated with
acutely enhanced processing of nociceptive signaling ori-
ginating from trigeminal-innervated deep cranial tissues,
due to meningeal mast cell degranulation [40]. These in-
juries/models did not affect central nociceptive process-
ing that originates in extracranial tissues, indeed. Thus,
in PTH it is plausible to hypothesize that direct trauma
to the head may be enough to initiate acute periosteal
and persistent dural mast cell degranulation for at least
30 days following a trauma, resulting in the development
of headache [40, 47]. On the other side, Bree and Levy
found that persistent activation of meningeal mast cells
after mCHI is not required for the development of ceph-
alic hypersensitivity, so that authors hypothesized that
CGRP mediates the PTH-related pain behavior through
a mechanism independent of ongoing meningeal mast
cells pro-inflammatory response [68].
As mentioned above, direct involvement of CGRP in
the pathophysiology of PTH has also been proposed.
Multiple cortical spreading depression events, as can
occur in the case of a TBI, upregulate in vivo CGRP
mRNA levels at 24 h in the cerebral cortex of concussed
rats, so that also CGRP levels can increase in discrete re-
gions of the ipsilateral cortex when compared with
contralateral cortex and the sham group (both ipsilateral
and contralateral cortices) [69]. This study provides evi-
dence for cortical spreading depression as a mechanism
to initiate and maintain elevated CGRP levels in post-
traumatic headache for a prolonged period [69]. Further-
more, other evidence comes from another study testing
the administration of a novel anti-CGRP monoclonal
antibody in a rat model of mCHI. Concussed rats devel-
oped cephalic tactile pain hypersensitivity that was ame-
liorated by sumatriptan or chronic blockade of CGRP
using anti-CGRP monoclonal antibody starting immedi-
ately after mCHI and every six days subsequently. By
two weeks, after the resolution of concussion-evoked
cephalic hypersensitivity, the administration of glyceryl
trinitrate produced a renewed and pronounced cephalic
pain hypersensitivity that was again inhibited by suma-
triptan or anti-CGRP antibody treatment [34].
An enhanced persistent susceptibility to migraine trig-
gers could represent another mechanism for PTH. Still
in the same rat model of mild concussive head injury,
after the resolution of cephalic hypersensitivity, the ad-
ministration of a low dose of GTN, acting as a migraine
trigger, resulted in the re-exacerbation of cephalic tactile
hypersensitivity up to 30 days post-injury as well as in a
significant conditioned place aversion, having in reverse
no effect in sham controls [34].
It is worth saying that current evidence, based on
available models, does not exclude the involvement of
peripheral damage to neck muscles, meninges, or other
deep cranial tissues. The involvement of these tissues
should be adequately investigated to define their differ-
ential role in PTH mechanisms, also to further under-
stand if and how they overlap those of migraine [70–72].
Conclusions
PTH is a common and disabling condition, for which we
still need to clarify general pathogenesis and crucial
mechanisms. Animal models have provided relevant in-
formation on the pathophysiology of PTH, but detailed
underlying mechanisms are not fully understood. Im-
portantly, recent data show a certain overlap with mi-
graine, probably reflecting the involvement of some
shared pathways. However, the evidence is currently ex-
tremely scarce. In order to better define the relation be-
tween migraine and PTH, and to improve specific
knowledge that could lead to targeted treatments, animal
models should be tailored to accurately resemble human
features and be systematically used to seek similarities
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